<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1392</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2014</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>28</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetes</title>
	<subject_fa>Endocrinology</subject_fa>
	<subject>Endocrinology</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt; &lt;strong&gt; Background &lt;/strong&gt;:Some results exist on fetuin-A as marker for vascular disease in type 2diabetes. We examined the relationship between serum fetuin-A with some factors, in patients with type 2 diabetes mellitus (T2DM). &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Methods &lt;/strong&gt;: From October 2012 to June 2013, a total of 131 T2DM patients were recruited and evaluated for various parameters including HOMA-IR, Apo-A1, Apo-B100, body fat percentage and waist circumference. Serum fetuin-A levels were measured by enzyme-linkedimmunosorbent assay (ELISA), and Serum glucose with a Cobas MIRA analyzer by enzymatic method. Apo-B100 and apo-A1 &lt;a name=&quot;_GoBack&quot;&gt;&lt;/a&gt;were measured by immunoturbidimetry with a Cobas MIRA analyzer. HOMA-IR was calculated by the following formula: [fasting insulin (uIU/mL) × fasting blood glucose (mmol/L)]/22.5. &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Results &lt;/strong&gt;: The mean levels of HOMA-IR were significantly increased progressively across fetuin-A tertiles (pfor trend=0.04) in women but not men. Fetuin-A had just a significant positive correlation withApo- A1(r=0.22, p=0.02). &lt;/p&gt;&lt;p&gt; &lt;strong&gt; Conclusion &lt;/strong&gt;: This present study showed that levels of serum fetuin-A are significantly associated with insulin resistance in women with T2DM. &lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Fetuin-A, Apo-A1, Apo-B100, Body Fat Percentage, Insulin Resistance, Type 2 Diabetes.</keyword>
	<start_page>646</start_page>
	<end_page>652</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-1-732&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Farzad </first_name>
	<middle_name></middle_name>
	<last_name>Shidfar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shidfar.f@iums.ac.ir   </email>
	<code>200319475328460014766</code>
	<orcid>200319475328460014766</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mitra</first_name>
	<middle_name></middle_name>
	<last_name> Zarrati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zarrati_ms@yahoo.com </email>
	<code>200319475328460014767</code>
	<orcid>200319475328460014767</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohamad Ebrahim </first_name>
	<middle_name></middle_name>
	<last_name>Khamseh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>khamseh.m@iums.ac.ir </email>
	<code>200319475328460014768</code>
	<orcid>200319475328460014768</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neda </first_name>
	<middle_name></middle_name>
	<last_name>Haghighat</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>neda.hag@gmail.com </email>
	<code>200319475328460014769</code>
	<orcid>200319475328460014769</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali </first_name>
	<middle_name></middle_name>
	<last_name>Rostami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ali.rostami.nut@gmail.com</email>
	<code>200319475328460014770</code>
	<orcid>200319475328460014770</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamid</first_name>
	<middle_name></middle_name>
	<last_name> Zolfaghari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>h.z.7025@gmail.com</email>
	<code>200319475328460014771</code>
	<orcid>200319475328460014771</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Institute of Endocrinology and Metabolism Research and Training Center, Iran University of Medical Sciences, Tehran, Iran. </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
